Cheshire, UK--(Marketwire - June 27, 2007) -
Protherics PLC
Documents lodged with the UK Listing Authority's
Document Viewing Facility
London, UK; Brentwood, TN; 27 June 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on
critical care and cancer, has today posted to shareholders its Annual
Report for the year ended 31 March 2007, which contains a notice of the
Company's Annual General Meeting to be held at 12.00 noon on Thursday 26
July 2007 at the offices of Ashurst, Broadwalk House, 5 Appold Street,
London EC2A 2HA (the "Meeting").
Copies of the above documents, together with copies of the Company's
Articles of Association and the Company's 2005 Deferred Bonus Plan, which
contain amendments to be proposed at the Meeting, have been lodged with
the UK Listing Authority's Document Viewing Facility and will shortly be
available for inspection at:
The Document Viewing Facility
Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, David Yates +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange